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Abstract 
Mobile mental health trackers, the mobile applications that gather self-reported mental 
logs from users, have gained recent attention from clinicians as a tool for detecting 
patients’ depression. However, critics have raised questions about the validity of the 
data collected from mental health trackers, which ask only a few simple questions using 
the face emoticon scale. Our research is the first study to address this issue, and we 
provide theoretical discussion that leads to the following hypotheses: (1) simpler but 
larger datasets collected daily from mobile mental health trackers can serve as good 
indicators to detect patients’ depression, and (2) higher adherence to mobile mental 
health trackers enhances screening accuracy. We tested our hypotheses using the 
dataset of 5,792 sets of daily mental health logs collected from 78 breast cancer patients. 
Our random logistic panel regression and ROC analysis results, as well as k-means 
clustering analysis, provide strong supports for both hypotheses. 
Keywords: Mobile health, Mental health trackers, PRO (Patient Reported Outcomes), 
Depression, ROC (Receiver Operating Characteristic), K-means clustering, Facial emoticon scales, 
Patient adherence 
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Introduction 
Recently, self-report-based mobile health applications, which are designed to collect daily health logs of 
patients, have become actively used in many large hospitals (Judson et al. 2013; Min et al. 2014). In 
particular, in chronic and severe disease treatment settings, mobile mental health trackers have gained 
special attention as a tool for routine psychological distress screening(Donker et al. 2013; Harrison et al. 
2011). Depression is a common symptom in patients in these settings, and early detection is imperative to 
prevent its adverse effects on patients’ treatment processes and health outcomes (Katon et al. 2005; 
Pozuelo et al. 2009). However, several factors deter early detection, such as lack of feasible screening 
instruments in routine settings and time constraints of both patients and clinicians (Gjerdingen and Yawn 
2007; Katon and Ludman 2003). The use of mobile mental health trackers is expected to help overcome 
those barriers and foster communication between patients and clinicians about patients’ mental status 
without time and space restrictions (Chatterjee et al. 2009), providing richer datasets that are otherwise 
not easily available in traditional treatment settings. The recent advancement of EMR (electronic medical 
record) systems, which have the capacity to efficiently integrate data from different sources, has further 
heightened the hope that clinicians will be able to detect patients’ mental status in real time based on daily 
logs reported via mental health trackers (Chatterjee et al. 2009). However, it is still unclear whether daily 
mental health log data, which use simpler instruments and are self-reported by patients through mobile 
mental health trackers, can be used to detect patients’ mental status for clinical purposes. Moreover, 
critics raise questions about the validity of the use of the face emoticon scale used in many mobile mental 
health trackers for depression screening. In addition, from a practical perspective, the expansive amount 
of daily data collected from patients through mobile mental health trackers can be a burden, especially for 
a large health care system. Therefore, it is crucial to develop a framework to distinguish useful data from 
data that may only increase noise, bias, and variability, the common pitfalls of mobile data (Chen et al. 
2012).  
Our study aims to provide a theoretical framework and empirical evidence of the efficacy of the use of 
daily mental health logs collected through mobile mental health trackers to screen patients’ mental status. 
We suggest that simpler but larger datasets collected daily from mobile mental health trackers can serve 
as good indicators to detect patients’ depression. Also, based on the adherence literature in medical 
research, we suggest that the criteria of activeness, timeliness, and persistence in using mobile mental 
health trackers are useful to categorize patients into groups that show different levels of screening 
accuracy. We tested our hypotheses using the data collected from breast cancer patients who received 
treatment in the largest hospital in South Korea. Using the unique and novel dataset of 5,792 daily mental 
health logs of 78 breast cancer patients gathered via a mobile mental health tracker called “Pit-a-Pat” 
during a 48-week span, we developed a model that identify patients’ depression in three areas: sleep 
quality, mood, and anxiety levels. The results of a random logistic panel regression provide evidence that 
daily mental health logs serve as a reliable tool for screening patients for depression. Also, by employing a 
k-means clustering algorithm, we categorized the patients into two groups based on their adherence level, 
which is determined by their activeness, timeliness, and persistence in using the mobile mental health 
tracker. The results show that the accuracy is significantly higher for patients in the high-adherence group 
than those in the low-adherence group.  
Our research has several strengths that provide important implications for both academic researchers and 
health care practitioners, in addition to the fact that our study is just one of a few studies that examine the 
mobile health trackers used by patients for clinical purposes. First, our study is the first to provide 
empirical evidence that daily mental health logs collected through mobile mental health trackers can serve 
as reliable indicators for detecting a patient’s mental distress. Although plenty of studies have discussed 
the role of mobile health trackers in supporting clinicians’ decision making, most of them focus on 
managerial suggestions and technical guidelines without sufficient empirical evidence(Albrecht 2013; 
Junglas et al. 2009). Empirical studies focus on evaluation of the feasibility of data collection without 
assessment of the usability of the data for clinical purposes (Harrison et al. 2011; Min et al. 2014; Reid et 
al. 2009). Our unique panel dataset of daily mental health logs combined with the screening results of 
traditional methods allows us to examine the validity of the mobile data for depression screening, while 
controlling for unobserved heterogeneity of patients or temporary external events that may cause 
estimation bias. 
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Second, our study is the first to empirically show the impact of patient adherence on health care quality in 
the mobile health trackers context. Although several studies mention the importance of patient adherence 
to reporting health logs via mobile health trackers (Katzan et al. 2011; Locklear et al. 2014; Snyder et al. 
2009), these studies focus on strategies to promote patient adherence to applications and system designs 
for data collection on mobile devices. Our study is unique in the sense that we empirically show the 
positive effect of patient adherence to self-reporting via mobile mental health trackers on the screening 
accuracy of patients’ mental status, extending prior studies that show the positive effect of patient 
adherence on health care outcomes in traditional healthcare settings (DiMatteo et al. 2002; Williams et al. 
1998, 2002). Our empirical evidence will alleviate patients’ burden in keeping daily logs by helping them 
understand the benefits of reporting daily via mobile mental health trackers(Locklear et al. 2014). Also, it 
may further motivate patients to adhere to the applications.  
Third, we provide a theoretical discussion on the framework for the potential of mobile mental health 
trackers as effective depression screening tools and a methodological approach for restructuring the 
format of daily mental health logs to identify depression. Unlike traditional paper-based screening tools 
such as PHQ-9(Patient Health Questionnaire-9), mobile mental health trackers gather data based on face 
emoticon scales, and both clinicians and users have raised concerns about the validity of this data, and, by 
extension, the validity of mobile mental health trackers as depression screening tools. Based on the 
psychological explanation about the positive effects of a short retention interval for mental status (Ayers 
and Reder 1998; Johnson et al. 1993; Odinot and Wolters 2006; Windschitl 1996) and studies confirming 
the accuracy of using face scales that express human emotions (Ekman et al. 1983; Goldman and Sripada 
2005) in depression screening, we address how brief questions on face emoticon scales serve as similar 
results of depression screening with traditional tools. Furthermore, based on clinical guidelines for 
identifying depression (American Psychiatric Association 2013; Kroenke and Spitzer 2002), we propose a 
methodological approach to identify depression determined in a biweekly period with mental health logs 
gathered daily.  
This paper is organized as follows. First, we provide the background of mobile mental health trackers and 
medical adherence. Next, we develop our hypotheses based on a review of relevant literature, followed by 
a description of the empirical design of this study. The results and discussion are provided.  
 
Background 
Mental Health Trackers for Depression in Oncologic Treatment 
Although depression has adverse effects on the decision making process of patients, their treatment 
effectiveness, recovery, and their mortality risks (Stommel et al. 2002; Trask et al. 2001), mental distress, 
when present, is detected far less than 30% of the time in cancer patients, due to time constraints of both 
patients and clinicians and the lack of self-assurance in receiving depression screening tests (Gessler et al. 
2008; Gil et al. 2005). To resolve these problems, brief screening tools consisting of just one or two self-
report questionnaires, such as the Distress Thermometer (DT) and the Patient Health Questionnaire-2 
(PHQ-2), are used (Gil et al. 2005; Mitchell and Coyne 2007). However, these screening methods are still 
problematic when dealing with those patients who rarely visit a doctor. To alleviate this issue, doctors 
recommend that such patients continue tracking Patient Reported Outcome (PRO) on paper as a form of 
mental status diary (Harrison et al. 2011; Turnbull Macdonald et al. 2012). However, due to the 
inconvenience of keeping daily logs on paper, the usage of such diaries is low (Harrison et al. 2011; Stone 
et al. 2002).  
With the rapid surge in the use of mobile devices, health providers wish to take advantage of mobile 
technologies by embedding instruments that can collect mental PRO via mobile applications. Despite the 
potential benefits of mental health trackers in the oncologic treatment setting, prior studies have focused 
on evaluating the feasibility of data collection and overall response rates (Harrison et al. 2011; Min et al. 
2014; Reid et al. 2009), without research on evaluating the validity of the data for depression screening. 
With this research, our intent is to close this gap.   
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Medication Adherence 
In the medical research, adherence is defined as a patient’s autonomous involvement in treatment plans1 
(Ho et al. 2009; Sandman et al. 2012) and is closely related to the concepts of “compliance” (Sandman et 
al. 2012).2 Traditional medical research broadly studies the effects of adherence on health outcomes and 
prescribes strategies for improving adherence in the treatment process. For the effect on health outcomes, 
a vast amount of research has shown that non adherence to medication results in worse treatment 
outcome and health status, an increased rate of hospitalization, and higher health management costs 
(DiMatteo et al. 2002; Ruddy et al. 2009; Sokol et al. 2005; Waterhouse et al. 1993). Several studies have 
also discussed strategies to promote adherence, such as increasing shared decision making between 
doctors and patients and doctor-patient communication (Robinson et al. 2008; Street et al. 2009). 
Despite the importance of adherence, to the best of our knowledge, there has been no discussion on the 
effects of adherence to self-reported PRO via mobile health trackers in helping clinicians to better detect 
patients’ mental status. We extend prior literature by considering adherence to self-report measures as 
the key factor determining the quality of PRO’s.  
 
Theoretical Framework and Hypothesis Development 
Traditional Screening Tools vs. Mobile Mental Health Trackers  
Mobile mental health trackers exhibit several distinctive characteristics compared with traditional 
screening tools for mental health assessment. Among them, two factors influence the accuracy of the 
screening results for patients’ mental status: (1) the depth and breadth of the survey instrument and (2) 
the frequency of data collection. In short, mental health trackers collect data in much simpler forms but 
with higher frequency (i.e., daily) than traditional screening tools (Figure 1). We posit that a simpler form 
of survey may reduce the accuracy of the test results, but the higher frequency of data collection reduces 
potential measurement errors, offsetting the total impact.  
While traditional tools such as PHQ-9 and BDI (Beck Depression Inventory) gather diverse information 
related to depressive symptoms on a long term basis (e.g, biweekly) (Beck and Alford 2009; Kroenke and 
Spitzer 2002), mobile mental health trackers ask patients to provide only a few items related to depressive 
symptoms on a short term basis (e.g., daily). Prior studies have shown that the accuracy of memory 
substantially decreases as the length of the retention period increases (Ayers and Reder 1998; Johnson et 
al. 1993; Odinot and Wolters 2006; Windschitl 1996). The memory retention issue is particularly critical 
for cancer patients, because their mental statuses are often unstable due to the side effects of cancer 
treatment (Badger et al. 2001; Vahdaninia et al. 2010). Thus, we expect that the use of mobile mental 
health applications can reduce memory errors. We also speculate that the use of a face emoticon scale has 
little significant harmful effect on the validity of the data and may in fact have a positive effect. A face 
emoticon scale is widely used in measuring pain and mental distress in mobile mental health trackers. 
Even though there has not been research directly examining the effectiveness of a face emoticon scale for 
detecting mental status in a mobile context, prior studies in psychology suggest that a face emoticon scale 
can be a good indicator of a patient’s mental status, because a face emoticon scale demands less cognitive 
effort and less of a burden in interpreting the items (Bieri et al. 1990; McKinley et al. 2003). Goldman and 
Sripada (2005) have shown that people infer another person’s mental status through his or her facial 
expression. Ekman et al. (1983) show through experiments that emotion can be reliably detected by facial 
muscle patterns. Also, a face emoticon scale can make the survey participation more enjoyable (Derham 
2011). On the other hand, readability of a text-based rating scale is significantly reduced on mobile devices. 
Peytchev and Hill (2009) examine the survey design for mobile environments through experiments and 
show that heavy text-based information beyond the visible display bothers participants, causing some of 
them to ignore the text-based information. Therefore, the use of a face emoticon scale fitted on a small 
display size may even facilitate user participation, potentially making the data more useful. In conclusion, 
                                                             
1 More specifically, the term “adherence” characterizes “patients as independent, intelligent, and autonomous people who take more 
active and voluntary roles in defining and pursuing goals for their medical treatment” (Lutfey and Wishner 1999; Sandman et al. 
2012).  
2 The term “compliance” is defined as ‘‘the extent to which a person’s behavior coincides with medical or health advice,”  
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we posit that a shorter survey instrument with a face emoticon scale is unlikely to diminish the accuracy of 
screening results of a mobile mental health tracker compared with traditional paper-based screening tools.  
Based on these arguments, we hypothesize that the larger dataset collected through mobile mental health 
trackers capturing the measures of a few appropriate distress symptoms at a much shorter time interval 
(i.e., daily) will serve as a good indicator for patients’ mental health status.  
H1: Daily mental health logs reported via mobile mental health trackers provide screening results for 
depression consistent with those determined by using traditional instruments. 
 
Figure 1. Difference in Data Collection between Traditional and Mobile Tools 
 
Adherence to Self-Reporting and Its Effects on Screening Accuracy 
Prior studies in medical research provide theoretical frameworks and empirical evidence that shows an 
association between a higher level of adherence to treatment plans and better health outcomes in the 
clinical setting. We posit that the positive effect of adherence on health care outcome can be extended to 
the context of mobile mental health trackers and suggest that higher adherence to mobile mental health 
tracking enhances screening accuracy for patients’ depression.  
The accuracy of a statistical prediction model is influenced by both quantity and quality of data (Guisasola 
et al. 2006), and we argue that a patient’s adherence to self-reporting can influence both dimensions. 
Sandman et al. (2012) suggests that a patient is more likely to adhere to a treatment when the patient has 
chosen that particular treatment through their own preference. Thus adherent patients tend to make 
additional efforts to successfully accomplish the suggested treatment plan. Extending this argument, in 
our context, we argue that adherent patients are likely to be the ones most interested in managing their 
mental distress and are also willing to actively participate in this additional intervention. As a result, we 
expect that adherent patients not only report more logs in a larger quantity (e.g. reporting logs more 
frequently and persistently) but also report logs of higher quality, because these patients report the logs 
with more meticulous care.  
We conceptualize adherence to mobile mental health tracking in three dimensions based on our review of 
prior literature: (1) activeness, (2) timeliness, and (3) persistence. First, activeness has been considered to 
be a primary indicator of a patient’s adherence level in medical research and refers to the degree of the 
patient’s activeness in adhering to guidelines (Lutfey and Wishner 1999; Sandman et al. 2012), often 
operationalized as the count of incidents of a patient’s active participation (Cramer et al. 1995; Kardas 
2005; Kronish et al. 2010; Paes et al. 1997). Second, timeliness captures a patient’s behavior in reporting 
daily mental health logs without delay. The World Health Organization (WHO) has introduced on-time 
appointment-keeping as an index for measuring drug resistance (World Health Organization 2010). Prior 
studies have used timeliness to measure patients’ attitude toward medication (Bastard et al. 2012; Blacher 
et al. 2010). Most daily logs gathered via mobile mental health trackers, including the applications used in 
this study, allow users to submit logs for the past few days. However, for cancer patients, delayed reports 
may contain biases, because they often experience high variations in their mental statuses due to the side 
effects of chemotherapy or medications (Badger et al. 2001; Vahdaninia et al. 2010). Therefore, reporting 
each set of mental health logs on the day of the report is highly recommended. Last, medication 
persistence is defined as continuous involvement with clinical treatment during the prescribed period 
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(Cramer et al. 2008). It is often characterized as a patient’s long-term attitude toward adhering to clinical 
guideline (Cramer et al. 2008; Lee et al. 2006) and is an important dimension of adherence, as routine 
depression screening is recommended throughout the whole cancer treatment period (Hopko et al. 2008; 
Pasquini and Biondi 2007; Tu et al. 2014). We consider a patient’s adherence to mobile mental health 
trackers as a composite construct of these three factors—activeness, timeliness, and persistency. They 
address different aspects of adherence, and there is no theoretical or empirical evidence that prioritizes 
the importance among the three. Moreover, the way patients adhere to mobile mental health trackers can 
vary across patients depending on their personalities. Some patients may prefer achieving short-term 
goals, while some patients are more enthusiastic about achieving long-term goals (Duckworth et al. 2007). 
In this regard, we still need to consider patients who submit only a few logs (low activeness) or submit the 
logs with delay (low timeliness) as having high adherence, if they are committed to using the applications 
during the entire course of the treatment (high persistence). Likewise, among patients who report daily 
logs frequently (high activeness) in over the long term (high persistence), we still need to distinguish 
patients who keep the logs on each day (high timeliness) from the ones who report the logs of past days on 
one day (low timeliness). 
Their sincere attitude toward submitting their mental health logs through mobile mental health trackers 
is expected to have a positive influence on the intended health care outcome, which is the accuracy of the 
depression screening. Thus, we hypothesize that 
H2: Depression screening accuracy is higher for patients who adhere to self-report measures, showing 
the active, timely, and persistent usage of mobile mental health trackers.  
 
Data and Methodology   
Data  
In early 2013, the largest hospital in South Korea developed a mobile application called “Pit-a-Pat” aiming 
to promote interaction between health providers and breast cancer patients and collect PROs of those 
patients, such as mental health logs, drug history, and side effect of medication. The hospital started 
providing the application to female breast cancer patients who consented to use the application in April 
2013. Among the PROs gathered by the application, we focus on three daily mental health logs: (1) anxiety, 
(2) mood, and (3) sleep satisfaction level, which have been demonstrated as symptoms or factors of 
depression in past literature (American Psychiatric Association 2013; Mayers et al. 2009; Seligman et al. 
2001). Figure 2 displays screenshots from the application. Questionnaires on anxiety and sleep 
satisfaction are displayed as a visual thermometer, and a questionnaire for mood is displayed using a face 
emoticon scale. Sleep dissatisfaction3 is measured on a scale of 0 (very good) to 10 (very bad), mood level 
is recorded on a scale of 0 (none) to 7 (very severe), and anxiety level is measured on a scale of 0 (none) to 
10 (very severe). 
Sleep satisfaction Mood Anxiety 
   
Figure 2. Snapshots of Three Self-Reporting Items 
 
                                                             
3 The application collects the sleep satisfaction level reported on a scale of 0 (very bad) to 10 (very good), but we reverse the scale to 
make it consistent with other measures (mood and anxiety) that take higher values as severity of depression increases.  
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Patient mental status is determined by results from PHQ-9, which is the most widely used depression 
screening tool in the primary care setting (Baldacci et al. 2013; Kravitz et al. 2013; Kroenke and Spitzer 
2002; Lazenby et al. 2014). PHQ-9 consists of nine items, and each item is scored 0 to 3. The total score 
calculated by aggregating the scores of nine items has a value of 0 to 27, and represents severity of 
depression. The questionnaire items are provided in Appendix 1. PHQ-9 tests were administered on a 
biweekly basis via the Pit-a-Pat application. 
 
Variables 
Dependent Variable: Patient’s Mental Status (Depressed) 
We constructed the outcome variable, which indicates whether a patient is depressed in a two-week 
period, based on the PHQ-9 test results. The outcome variable, Depressed, takes the value of 0 if the 
PHQ-9 score is below 5 and one if the PHQ-9 score is greater than or equal to 5.   
Severity of depressive symptoms on PHQ-9 is measured by the number of days that patients have 
symptoms related to depression over the two-week period (Kroenke and Spitzer 2002). Specifically, 
patients in the study score each severity of nine distress symptoms as 0 for ”not at all,” 1 as “two to six 
days,” 2 as “seven to 13 days,” and 3 as “every day,” respectively. The scores of nine items are aggregated 
to determine the severity of depression, providing a total score of 0 to 27 (Kroenke and Spitzer 2002). As 
a treatment action guideline, five levels of depression severity are classified as “None” if scored 1 to 4, 
“Mild” if scored 5 to 9, “Moderate” if scored 10 to 14, “Moderately Severe” if scored 15 to 19, and “Severe” 
if scored 20 to 27 (Kroenke and Spitzer 2002). Along the 27-point scale, we used a conservative cutoff of 5 
to determine depression, the criterion that has been widely used in prior research (Baldacci et al. 2013; 
Kravitz et al. 2013; Lazenby et al. 2014; McLennon et al. 2014). This conservative approach reduces the 
possibility that the cancer patients who have depressive symptoms are classified as normal. Several 
studies have reported that depression severity tends to be underestimated in the cancer treatment setting 
(Fann et al. 2008; Hardman et al. 1989; Hegel et al. 2006), despite the high cost of failing to detect 
depression due to its negative impact on health outcomes (Stommel et al. 2002; Trask et al. 2001). For 
this reason, in the depression treatment setting, researchers put more emphasis on improving a true-
positive rate rather than a true-negative rate (Kroenke and Spitzer 2002), because it is far more important 
to correctly identify depressed people rather than correctly identify normal people. Therefore, we used the 
conservative cutoff value of 5.  
Key Indicator Variable: Daily Mental Health Logs (Anxiety, Mood, Sleep) 
As described earlier, mental logs were collected daily, while PHQ-9 tests were conducted biweekly. Due to 
the difference in the level of observations between mental logs (i.e. daily) and PHQ-9 results (i.e. 
biweekly), we reconstructed daily mental logs into a biweekly format. Three different approaches for 
aggregation are considered and we refer to them as the (1) average, (2) frequency, and (3) ratio approach. 
First, the average approach is used to measure the severity of depression during a two-week period by 
calculating the average of each type of mental logs of a patient during the period. However, because an 
average tends to be sensitive to outliers, practical guidelines suggest measuring the severity of depression 
by counting the number of days that people have symptoms related to the depression during specified 
periods (Association American Psychiatric 2013; Kroenke and Spitzer 2002). For this reason, for the latter 
two approaches, the frequency and the ratio approach respectively, we first determined the days with 
depressive symptoms by assigning a score of 1 to the days when the reported scores were above a certain 
cutoff value. For example, if a score of sleep quality on a day was higher than a cutoff value, say 7, we 
considered the patient to be depressed on the day and assign the value of 1 to the day for the patient. The 
optimal cutoff values for each type of mental health logs were determined by employing Receive 
Operating Characteristic (ROC) analysis; the detailed procedures are provided in Appendix 2. The 
frequency approach counts the number of days with depressed symptom during a two-week period. The 
ratio approach calculates the ratio of the number of depressed days to the total number of days that the 
logs are reported during a two-week period.  
Each approach includes pros and cons. As per discussion, the average approach was susceptible to outliers, 
and failed to account for mental states on the days when a patient did not report logs. The frequency 
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approach may underestimate depressive severity of patients who seldom report daily mental health logs, 
because it fails to account for omitted logs as well. On the other hand, the ratio approach may 
overestimate depressive severity when numerous omitted mental health logs are present. We consider 
that the ratio approach is more appropriate for our context, because correctly identifying the depressed 
state is preferred to correctly identifying the normal state (Kroenke and Spitzer 2002). Thus, we use the 
ratio approach for our main analysis, but we also display the results of the other approaches as well. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Illustration of Data Conversion from Daily Mental Health Logs to Biweekly 
Indicators 
 
Classification of Patients According to Adherence Level   
We classified patients into a higher adherence group and a lower adherence group based on three factors: 
activeness, timeliness, and persistence. Activeness is operationalized as the total number of days when 
daily mental health logs are reported. For timeliness, we measure the total number of days when the logs 
were reported on the same day of the report. Persistence is measured with two variables: (1) the number 
of biweekly periods between the first and last days with reported daily logs (i.e., total duration) and (2) the 
total number of biweekly periods with reported logs. The total duration is an important dimension of 
persistence, because it captures a discontinuity effect of the patients who stop using the application after a 
few weeks. However, there can be the case where a patient reports only two logs, one very early and the 
other later in the study period. Therefore, we also consider the number of biweekly periods with reported 
logs. It is still different from activeness, because this measure captures the low adherence of patients who 
reported logs very actively only during the first few weeks and then seldom used the application. 
 
 Variable Description 
Depression 
Screening 
Depressed 0 if normal (PHQ-9 score < 5) and 1 if depressed (PHQ-9 score ≥ 5) 
Sleep The ratio of the number of depressed days determined by sleep log 
to the number of sleep logs reported during a period 
Mood The ratio of the number of depressed days determined by mood log 
to the number of sleep logs reported during a period 
Anxiety The ratio of the number of depressed days determined by anxiety 
log to the number of sleep logs reported during a period 
Adherence 
Classification 
Activeness The total number of days when daily mental health logs are 
reported during the study period 
Timeliness The total number of days when a patient reported mental health 
logs on the day of the report 
Persistence(1)  The total number of biweekly periods between the first and last 
observations 
Persistence(2) The total number of biweekly periods with reported logs  
Table 1. Description of Measurements 
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Model Specification and Clustering 
Our model is to identify patients’ mental status with three types of mental health logs:    
Depressed,	 	= Sleep,	 +	Mood,	 +	Anxiety,		 +	, 
Subscripted i and t indicate each patient and each biweekly period, respectively. The dependent variable, 
Depressed, takes a binary value (0=normal, 1=depressed). Because our primary interest is to assess the 
extent to which daily mental health logs can identify patients’ depression, we do not include control 
variables in our main model. However, we conduct a robustness check with the model that includes 
demographic information (cohabitation, education level, marital status, divorce status, age, the number of 
children, job status) to see if any important information is omitted.  
The model parameters are estimated using a logistic random-effect regression. We use a logistic 
regression model because the dependent variable is a binary variable. For panel analysis, we employ a 
random-effect model instead of a fixed-effect model, because of the superior estimation efficiency of a 
random-effect model. As we will describe in the next section, our dataset is a short panel, meaning that 
the number of patients is far greater than the number of time span of observations. Therefore, estimation 
efficiency can be an issue with a fixed-effect model, because the model should also estimate the 
parameters of the dummy variables of which number is the same as the number of patients in our sample. 
It significantly reduces the degree of freedom of the estimation and makes the estimation relatively 
inefficient. Moreover, our dataset is unbalanced, meaning that it contains some patients who reported a 
PHQ-9 test result only once. All these patients will be dropped from analysis if the model is estimated 
with a fixed-effect model. Therefore, a random-effect model is preferred in our situation. A potential issue 
of a random-effect model is that the estimation parameters can be biased, if the indicator variables (sleep, 
mood, anxiety) covariate with the error terms due to unobserved patient-specific factors. As mentioned 
above, we test the model with various patient-specific factors as controls, and the results show little 
evidence that three types of mental health logs are endogenous. Robust standard errors are reported for 
potential heteroskedasticity issues. 
We evaluate the screening accuracy of our model by employing Receiver Operating Characteristic (ROC) 
analysis. ROC is a graphical plot, which is widely used to demonstrate the prediction accuracy of a 
classifier model. It plots the true positive rate (i.e. sensitivity) against the false positive rate (i.e. 1-
specificity) at various threshold values. Therefore, unlike a confusion matrix, it does not require 
researchers to select an arbitrary cut-off value to calculate the true/false positive rate, while providing all 
necessary information. The area under the ROC curve, which is referred to as an Area Under Curve (AUC), 
is interpreted as the probability that a classification model ranks a positive case higher than a negative 
case. Therefore, a higher AUC implies a better prediction performance of a classification model.  
To classify patients based on their adherence level, we use a k-means clustering algorithm. K-means 
clustering classifies subjects into homogeneous subgroups, where each observation belongs to the cluster 
with the nearest intra-cluster distance and with the largest inter-cluster distance. The mechanism is to 
minimize the intra-cluster sum of squares as partitioning the n data into k heterogeneous subsets 
(mathematically, min S = ∑ ∑ | − |
 
!	∈	#$
%
&'  where  represents (
) dimensional vector and μ is 
the mean of points). The procedure starts by randomly assigning  to k sets. Next, the mean of the 
cluster is calculated. Those steps are repeated until assigning  to k sets does not make any change. 
 
Results 
Sample Description 
A total of 85 breast cancer patients consented and participated in this study, and they submitted 5,817 
daily mental health logs from early April 2013 to late March 2014. We excluded 25 logs reported by seven 
patients who did not take any PHQ-9 tests during the sample period. As a result, 5,792 daily mental health 
logs reported by 78 patients were included in the analysis. The daily mental health log data were 
restructured according to the procedure described in the earlier section to match biweekly PHQ-9 test 
results. The 78 patients in our sample reported a total of 497 PHQ-9 test results, which consists of 270 
normal statuses and 227 depressed statuses. Our data constitute an unbalanced panel of 78 patients for 24 
biweekly periods. On average, we have 6.4 observations per patient. Eleven patients are observed only 
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once, and we have 24 observations for one patient. Table 2 provides summary statistics and a correlation 
matrix of key variables. For the 78 patients, we also collected their demographic information, including 
age, cohabitating status, number of children, marital status, education level, and employment status. Also, 
we include baseline information for patients’ depression status measured using the BDI.  
 
 N Mean Std.d Min Max Depressed Sleep Mood Anxiety 
Depressed 497 0.46 0.50 0.00 1.00 1.00    
Sleep 497 0.21 0.23 0.00 1.00 0.36*** 1.00   
Mood 497 0.40 0.38 0.00 1.00 0.42*** 0.38*** 1.00  
Anxiety 497 0.30 0.32 0.00 1.00 0.40*** 0.22*** 0.47*** 1.00 
Table 2. Summary Statistics and Correlation Matrix of Key Variables (Ratio Approach) 
 
 
Dependent variable: MentalStatus, which is 0 if normal (PHQ-9 score < 5) and 1 if depressed (PHQ-9 
score ≥ 5) 
 Model I  Model II Model III Model IV Model V 
Mental logs      
Sleep 
3.712*** 
(0.890) 
  
2.722*** 
(0. 767) 
2.957*** 
(0.734) 
Mood  
2.973*** 
(0.607) 
 
1.783*** 
(0. 596) 
1.009* 
(0.599) 
Anxiety   
2.680*** 
(0.598) 
1.782*** 
(0.661) 
2.076*** 
(0.637) 
BDI     
0.104*** 
(0.033) 
Demographic 
Controls1 
No No No No Yes 
Constant 
-0.964*** 
(0.354) 
-1.258*** 
(0.339) 
-0.969*** 
(0.317) 
-1.965*** 
(0.372) 
-4.169** 
(1.498) 
Num. of Obs. 497 497 497 497 496 
Num. of 
Patients 
78 78 78 78 77 
Log likelihood -264.1454 -258.0548 -265.479 -245.952 -234.4229 
Wald χ² 25.87*** 39.00*** 26.99*** 58.31*** 74.66*** 
1. The demographic controls are cohabitation, education level, marital status, divorce status, age, number 
of children, and employment status.  
Note: The 497 observations are constructed from a total of 5,817 daily mental health logs reported via the 
mental health tracking application. Random effects on patients. Robust standard errors are in 
parentheses. ∗ significant at < 10%; ∗∗significant at < 5%; ∗∗∗significant at < 1%. 
Table 3. The Results of Random Effect Logistic Panel Regression 
 
Random Effect Logistic Panel Regression Results (Ratio Approach)  
Table 3 provides the random-effect logistic panel regression results. First, we examine the statistical 
power of each type of mental health log (sleep, mood, anxiety). Models I to III are the models that identify 
patients’ mental status using one type of mental health log. The Wald χ² test results support our finding 
that all models are statistically valid. The coefficient of the mental health log in each model is statistically 
significant at the 1% level, supporting our hypotheses that the variables constructed using daily mental 
health logs are statistically significant indicators for patients’ mental status. Next, we examine the effects 
of all three types of mental health logs in a single model. In Model IV, all three types of mental health logs 
are statistically significant in detecting patients’ mental status at the 1% significance level. This result 
indicates that each type of mental health log addresses different dimensions of patient mental status. For 
example, consider the case when two patients reported the same level of anxiety and mood condition but 
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differing sleep conditions. Our result suggests that the difference in their sleep condition is a significant 
factor that determines their mental status. Holding other variables fixed, a one-tenth unit (0.1) increase in 
Sleep (i.e., the increase in the ratio of depressed day to the total number of reported days in a given 
biweekly period by 0.1) is associated with a 31.3% increase in the odd of the patient being depressed since 
exp(0.272) = 1.313. Similarly, all other things being equal, a one-tenth unit increase in Mood and Anxiety 
is associated with a 19% increase in the odd of the patient being depressed, respectively. The LR test 
comparing Model IV with Models I–III shows that the integrated approach (Model IV), which uses all 
three types of mental health logs, explains depression better than the single-indicator model at the 1% 
significance level. Last, in Model V, we include demographic information and the BDI at the start of using 
the application as controls. The results show that all demographic controls are statistically insignificant. 
Consistent with our expectation, the coefficient of BDI is statistically significant at the 1% significance 
level, suggesting that the initial depression level of a patient is statistically positively associated with the 
depression level in the study period. Even after controlling for various patient-specific factors, mental 
health log variables are still statistically significant at the 10% level. 
ROC Analysis Results 
Figure4-(1) shows the ROC plots of the prediction results obtained from the logistic regression analysis in 
Table 3 and the corresponding AUC’s. Each line shows the ROC of Models I–IV. The AUC’s calculated 
from the ROC of integrated logs, a sleep log, a mood log, and an anxiety log are 0.8012, 0.7105, 0.7403, 
and 0.7340, respectively. This result is consistent with the LR test result, which shows a superior model fit 
of Model IV. The differences between the AUCs of Model IV and other models are statistically significant 
at the 1% level, suggesting that the screening accuracy of Model IV is significantly higher than the single-
indicator models. In particular, the slope of ROC of Model IV is steeper than the others, indicating that 
Model IV can correctly identify depressed patients as depressed (i.e., a high true-positive rate) with a 
lower risk of identifying normal patients as depressed (i.e., a low false-positive rate) than the other 
models.  
 
(1) Full Samples (2) ROC by Three Approach  (3) ROC by Adherence Levels  
   
Figure 4. ROC Analysis 
 
We conducted additional analyses to check the robustness of our results. First, we conducted the 
regression and ROC analysis using the alternative approaches for restructuring daily data using a 
biweekly format. Figure 4-(2) shows the results of the average approach and the frequency approach along 
with the results of the ratio approach, which are identical to the results of Model IV in Figure 4-(1). The 
results of the average and the frequency approach are generally consistent with those of the ratio 
approach. For the average approach, the coefficients of all three types of logs are statistically significant at 
the 5% significant levels, and the AUC of the ROC curves is 0.7867. For the frequency approach, the 
coefficients of Sleep and Mood are statistically significant, and the AUC of the ROC is 0.7634. The results 
of these alternative approaches suggest that the validity of the use of daily mental health log data is robust 
to the different approaches. The results also suggest that the prediction accuracy of the model with the 
ratio approach is the highest, supporting our selection of the ratio approach for our main analysis. The 
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AUC with the ratio approach is higher than the ones of the other approaches. Even though the difference 
between the ratio and average approach is not statistically different, it is statistically different between the 
ratio and the frequency approach.  
Second, we tested the validity of our model by employing the fivefold cross-validation procedure to 
examine whether our models overfit the data. We (1) randomly partition the data into five subsets where 
the sample size is approximately 100, (2) run a random effect logistic regression using four of the subsets 
as a training set, (3) then calculate the predicted probability for the remaining subset as a test dataset, and 
(4) employ ROC analysis and calculate the AUC. Steps (1) through (4) are repeated five times by 
alternating training and test datasets. For the ratio approach, the resulting AUCs of the five subsets range 
from 0.7537 to 0.8568. The AUC of the aggregated results of the five subsets is 0.7937. For the average 
approach, the AUCs range from 0.7234 to 0.8488, and the AUC of the aggregated result is 0.7755. The 
resulting AUCs of the frequency approach range from 0.7177 to 0.8188, and the AUC of the aggregated 
result is 0.7550. The results suggest that the risk of overfitting is not high with our models, as the 
screening accuracy does not significantly decrease when the model is applied to the dataset not used for 
building a model.  
Patient Adherence and Screening Accuracy 
We analyzed the difference in depression screening accuracy between high and low adherence groups, 
which are classified by the k-means clustering algorithm. 
 
 # of patients # of obs. Activeness Timeliness Duration Persistence 
Total 78 497 68.55 51.31 6.59 6.45 
Lower adherence 58 208 37.66 29.81 3.79 3.67 
Higher adherence 20 289 158.15 113.65 14.70 14.50 
ANOVA Test* : 
F (1,76)  
- - 265.25*** 176.29*** 171.56*** 181.08*** 
* Ho: Mean of lower adherence = Mean of higher adherence 
Table 4. Mean of Key Variables by Groups Classified by K-means Clustering 
 
Table 4 provides descriptive statistics of four variables for the two groups classified with the k-means 
clustering algorithm. “Higher adherence” refers to the group for which the mean values of the four 
variables are higher, and “lower adherence” refers to the other group. Among 78 patients, 58 patients are 
classified into the lower-adherence group, and 20 patients are classified into the higher-adherence group. 
Among the 497 observations in the biweekly panel dataset, there are 208 observations for the patients in 
the low-adherence group, and 289 observations for the patients in the high-adherence group. The ANOVA 
test results shows that the difference between the two groups are statistically significant at the 1% level. 
Figure 4-(3) shows the ROC curves and the statistical test results that compare the screening accuracy 
according to two groups of adherence levels (high and low). With the ratio approach, AUCs of the higher-
adherence group (0.8524) are significantly higher than the AUCs of the lower adherence group (0.7234) 
at the 1% significance level. These results show that the depression screening accuracy of patients who 
adhere to self-reporting on daily mental health logs is higher than the accuracy of patients who do not. 
The results with the average approach (the higher adherence: 0.8425, the lower adherence: 0.7016) and 
the frequency approach (the higher adherence: 0.8259, the lower adherence: 0.6664) are consistent with 
our findings. 
One may suggest that there can be another factor that affects both depression and adherence, causing 
potential endogeneity issues. For example, what if patients with depression tend to adhere to self 
reporting?4 We examined such a possibility by analyzing whether other available variables such as a 
patient’s demographic information (i.e. age, cohabitating status, number of children, marital status, 
education level, and occupation status) and baseline mental information (BDI) were associated with their 
adherence level. We conducted t-test and Pearson’s χ² test, and the results show that the adherence level 
                                                             
4 We appreciate the anonymous reviewer for this point.  
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is not statistically associated with any of variables we tested. The random effect logistit analysis which use 
the clustering result (1=the higher adherence, 0=the lower adherence) as a dependent variable also 
supports that no other factors except their marital status are related to an adherence level at the 10% 
significance level. When marital status is incorporated into the model, the model fails to converge. These 
results suggest that the risk of endogeneity due to other factors affecting depression and adherence is not 
high. 
 
Comparisons Layers Adherence   
Average 
Approach 
Ratio 
Approach 
Frequency  
Approach 
AUC Sig. AUC Sig. AUC Sig. 
The 
Comparison 
of AUCs in 
Six Months 
and Without 
Late Starters 
Six 
Months 
Lower (n=161) 0.7239 
0.033 
0.728 
0.016 
0.6774 
0.007 
Higher (n=336) 0.8205 0.8364 0.8088 
Without 
Late 
Starters 
Lower (n=171) 0.7015 
0.001 
0.7405 
0.006 
0.6796 
0.002 
Higher (n=273) 0.8540 0.8599 0.8283 
The 
Comparison 
of AUCs by 
Only a Single 
Mental 
Health Log 
for the Study 
Period 
Sleep 
Lower (n=208) 0.5938 
0.000 
0.6102 
0.001 
0.5811 
0.000 
Higher (n=289) 0.8160 0.7746 0.7639 
Anxiety 
Lower (n=208) 0.6922 
0.048 
0.6703 
0.029 
0.642 
0.011 
Higher (n=289) 0.7816 0.7724 0.7629 
Mood 
Lower (n=208) 0.6802 
0.000 
0.6783 
0.035 
0.656 
0.002 
Higher (n=289) 0.8353 0.7752 0.7985 
The 
Comparison 
of AUCs 
According to 
Three 
Three 
Groups 
Lower (n=113) 0.7134 
0.020 
0.6767 
0.006 
0.6003 
0.002 Middle (n=159) 0.7542 0.7893 0.7986 
Higher (n=225) 0.8446 0.8512 0.8114 
Table 5. Robustness Test Results   
 
We also conducted four additional tests to check the robustness of our finding that the screening accuracy 
is higher for patients with a higher level of adherence. First, we examined whether the difference in length 
of data collection periods by patients influences the results. Our main analysis considers the whole study 
period (48 weeks) to examine the effect of patient adherence. However, each patient started using the 
application at a different time during the study period, and the measure of persistence can be biased for 
patients who started using the application very early or very late. For example, persistence can be 
underestimated for patients who started using the application later in the study period, because they 
simply had fewer days to report their daily logs. Likewise, persistence can be overestimated for patients 
who started using the application earlier, because they spent more days with the application. Therefore, 
we evaluated whether our results are maintained if we consider only the log data collected during the first 
24-week period for each patient. We re-ran the analysis, and the results are provided in Table 5. The 
result is consistent with our main result. Second, as an alternative way to address the concerns for the 
different time frames for patients, we repeated the analysis with the data subset by excluding patients who 
joined the study during the last 12 weeks, which is the average usage period of the patients in our sample. 
The result is provided in Table 5 and is consistent with our main results. Third, we examined whether the 
result holds when only one type of mental health log is used for the detection. The result in Table 5 shows 
that the effect of adherence on screening accuracy is maintained when only one type of mental health log 
is used for the detection. Fourth, we examined whether the results are maintained when patients are 
classified into three groups instead of two. This analysis is conducted to address the concern for outliers in 
each group (high and low), which may have driven the results. We re-clustered patients into three groups 
based on four variables. The ANOVA test results support that the differences between three groups are 
statistically significant at the 1% level. The results still support that the screening accuracy is higher for 
patients with a higher level of adherence still holds (p < 0.05) with the three-level classification (Table 5). 
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Discussion  
Our study has several limitations that provide opportunities for future research. First, we determine 
patients’ status based not on doctor’s diagnosis results but on a screening instrument, PHQ-9 in this study. 
Therefore, our result should not be interpreted as the usefulness of mobile mental health trackers as a 
diagnostic tool for depression. Instead, we show that a mobile mental health tracker can be used as a 
screening tool to identify patients who have depressive symptoms. Therefore, for future research, it will be 
worthwhile to evaluate whether mobile mental health trackers can be used as a tool to diagnose patients’ 
mental distress by comparing the results with doctors’ clinical diagnoses. Second, although we conduct 
cross-validation tests and several robustness checks, our approach may still have a potential overfitting 
issue. We account for the number of depressive days that patients experienced during the specified period 
to construct explanatory variables, and this approach is similar to how a PHQ-9 test evaluates depressive 
severity. Therefore, although our study paves an important step in mobile mental health tracker research 
by proposing a new methodological approach to use daily mental health logs for depression screening, we 
believe a methodological improvement for alternative specifications for measurements and a detection 
model is an interesting area to investigate. Third, we consider three types of mental health logs collected 
from the application considered in this study. However, there is no standard way to collect mental health 
logs, and there has been no study on how depression questionnaires should be designed for the mobile 
environment. Some mobile mental health trackers ask only one brief, vague question, such as “how are 
you today?” Although short instruments are recommended to reduce burdens of reporting PRO (Locklear 
et al. 2014), our empirical results show that the depression screening accuracy is highest when all three 
types of logs are used rather than when only one type of log is used. Therefore, a natural extension of our 
study will be investigating the optimal design of mobile mental health trackers. Future study may also 
consider the effect of push alerts to promote adherence to self-reporting; mobile features like SMS 
messages have been shown to be effective in promoting adherence to medication and treatment plans 
(Armstrong et al. 2009; Free et al. 2013; Strandbygaard et al. 2010). Fourth, our study is conducted in a 
specific disease treatment setting in South Korea—depression screening for breast cancer patients. 
Therefore, our empirical evidence may not be generalized for other types of mental illness or for patients 
with different diseases, especially for patients with more severe disease, such as pancreatic and rectal 
cancers. Furthermore, South Korea has one of the highest percentages of smartphone users compared 
with other countries5. Accordingly, application development technology and data management skills there 
are considered to be of high quality. Therefore, the implications from our study may not be applied in an 
environment where complementary infrastructures are not adequately supported. In this regard, our 
study warrants further research on the assessment of the use of mobile mental health trackers in other 
settings. Last, many wearable devices are deployed by mobile healthcare applications. Such technology 
diffusion may not only further reduce patents’ effort to report their health status but also improve the 
quality of signals by automating capturing of them. We plan to extend our study with wearables.  
Despite these limitations, our study contributes to the academic research in several ways and provides 
important practical implications for health care providers. First, our study is the first attempt to identify 
mental distress based on daily mental health logs gathered through mobile mental health trackers. 
Although several mental health applications have been adopted as a means to overcome the limitations of 
traditional instruments for routinized depression screening (Min et al. 2014; Reid et al. 2009), there has 
been little discussion on the performance of mobile mental health trackers for clinical purposes. In 
particular, critics question the validity of relatively simple questionnaires and use of face emoticons by 
mobile mental health trackers. Our results show that depression screening using daily mental health logs 
via mobile mental health trackers can be a reasonable alternative to screen patients’ depression, 
supporting the potential of mobile mental health trackers for early detection of depression. Second, we 
provide a new perspective on measuring adherence to self-reporting by using a multidimensional 
construct, consisting of activeness, timeliness, and persistence. Prior empirical studies on adherence to 
mobile PRO tend to focus only on activeness (e.g., the total number of logs), without considering that an 
overall adherence level can decrease as time goes by (Judson et al. 2013; Min et al. 2014). By 
incorporating the degree of a patient’s autonomy to report on the right occasion (timeliness) during the 
whole treatment period (persistence), our framework enables us to capture the time effects in both the 
short-term and long-term horizons, an element that has been missing in prior research. Third, our 
                                                             
5 http://think.withgoogle.com/mobileplanet/en/ 
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empirical evidence emphasizes the critical role of adherence to self-reporting, providing important lessons 
for both doctors and patients. Our results show that the depression screening accuracy of mental health 
logs is much higher for high-adherence groups (AUC: 0.8524) than for lower-adherence groups (AUC: 
0.7234). Reporting daily mental health logs can be a significant burden for patients and can have an 
adverse effect on their mental status (Donaldson 2004; Snyder et al. 2009). These burdens can be 
reduced if patients recognize the clinical benefits of reporting their outcomes (PRO) (Locklear et al. 2014). 
Our empirical evidence can help patients understand the positive effect of adherence and provide 
motivation to adhere to self-reporting to improve the quality of treatment.  
Because mental illness is a subjective disease and cannot be detected based on biological states such as 
blood pressure and body temperature, psychiatrists identify depressed patients based on patient 
testimony. Mental health trackers can be a good solution for connecting patients and doctors and 
promoting their communications. Our study lays the foundation for research on mental health trackers in 
the clinical setting. We provide empirical evidence of mental health trackers as a depression screening 
tool and highlight the importance of patients’ active participation in mental treatment plans. We hope to 
see further research on mental health trackers, which are interesting and innovative approaches that will 
benefit both patients and doctors.  
 
Appendices 
A1. PHQ-9 Questionnaire Items (Kroenke and Spitzer 2002) 
1. Little interest or pleasure in doing things; 2. Feeling down, depressed, or hopeless; 3. Trouble falling or 
staying asleep, or sleeping too much; 4. Feeling tired or having little energy; 5. Poor appetite or overeating; 
6. Feeling bad about yourself, or that you are a failure or have let yourself or your family down; 7. Trouble 
concentrating on things, such as reading the newspaper or watching television; 8. Moving or speaking so 
slowly that other people could have noticed, or the opposite—being so fidgety or restless that you have 
been moving around a lot more than usual; 9. Thoughts that you would be better off dead or of hurting 
yourself in some way. 
A2. Calculating Cutoff Values 
To find the optimal cutoff value, we conduct ROC analysis. We calculate the optimal cutoff value of each 
mental health log by running a model in which a mental status is identified by only one type of mental 
health log with an arbitrary cutoff value and comparing AUC for all possible cutoff values. For example, to 
determine the cutoff for the Sleep variable, we (1) select an arbitrary cutoff value, c, (2) calculate the ratio 
or the frequency to get the Sleep variable as described in the measurement section (see Figure 3), (3) 
estimate the following model, Depressed,	 = Sleep,, - + 	,, -, and (4) get AUC from ROC analysis. As the 
sleep log data can take the value from 0 to 9, we obtain nine AUCs by repeating this process nine times. 
Among the nine candidate cutoff values from one to nine, we select the cutoff values that maximize AUC 
as the optimal cutoff values. For both the ratio and frequency approaches, the optimal cutoff values for 
sleep, anxiety, and mood are identified as seven, six, and four, respectively.   
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